Equity Analysis

Quarterly Results

    Suven Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    543064
    INE03QK01018
    86.6610444
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    SUVENPHAR
    108.67
    26860.42
    EPS(TTM)
    Face Value()
    Div & Yield %:
    9.71
    1
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales236.06222.09243.52
Other Operating Income0.000.000.00
Other Income 13.4317.9516.87
Total Income249.49240.04260.39
Total Expenditure 135.05139.05171.38
PBIDT114.44100.9989.01
Interest 1.471.602.29
PBDT112.9799.3986.72
Depreciation12.2912.0015.66
Tax27.9120.0218.69
Fringe Benefit Tax0.000.000.00
Deferred Tax-3.562.30-1.07
Reported Profit After Tax76.3365.0753.43
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item76.3365.0753.43
EPS (Unit Curr.)3.002.562.10
EPS (Adj) (Unit Curr.)3.002.562.10
Calculated EPS (Unit Curr.)3.002.562.10
Calculated EPS (Adj) (Unit Curr.)3.002.562.10
Calculated EPS (Ann.) (Unit Curr.)11.9910.228.40
Calculated EPS (Adj) (Ann.) (Unit Curr.)11.9910.228.40
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity25.4625.4625.46
Reserve & Surplus2180.630.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)48.4845.4736.55
PBDTM(%)47.8644.7535.61
PATM(%)32.3329.3021.94
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.982.562.10